|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Calcitonin Gene-related Peptide (CGRP) Monoclonal Antibodies Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application Calcitonin Gene-related Peptide (CGRP) Monoclonal Antibodies Market Summary The Calcitonin Gene-related Peptide (CGRP) monoclonal antibodies market ... These biologic therapies, engineered as fully humanized or human IgG2 monoclonal antibodies, precisely ... Akela Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... is a patented synthetic analogue of the natural human growth hormone releasing hormone, and ... -a-day extended pain release. CGRP or Calcitonin Gene Related Peptide Asthma The companys CGRP is a therapeutic ... Global Cancer Diagnostics Market 2013 France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies Complete report $32,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Summary This comprehensive seven-country report contains 1,200 pages, 450 tables, and presents analysis of the major business opportunities emerging in the cancer ... 2017 Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. VPGMarketResearch.com ... Immunotherapy Drugs Market Global Immunotherapy Drugs Market – Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025 [104 pages report] This market research report includes a detailed segmentation of the global immunotherapy drugs market by drug type (monoclonal ... Global Migraine Therapeutics Market Size study & Forecast, by Therapeutics (Pain-relieving Medications, Preventive Medications), by Route of Administration (Oral & Nasal, Injectables), and Regional Analysis, 2022-2029 ... Medicinal Products for Human Use (CHMP) recently approved Rimegepant, a calcitonin gene-related peptide (CGRP) receptor ... |